Malangoni M A, McCoy D M, Richardson J D, Flint L M
Ann Surg. 1985 May;201(5):554-9. doi: 10.1097/00000658-198505000-00003.
The efficacy of palliative biliary decompression by operative and percutaneous methods was evaluated in 106 patients with unresectable malignancies obstructing the biliary system. Seventy patients had operative and 36 had percutaneous decompression. Primary malignancies of the pancreas and bile ducts were most common. Percutaneous transhepatic decompression was achieved beyond the site of obstruction in 72% of patients. Overall hospital mortality was 25% for patients having percutaneous catheter decompression and 17% for those patients operated upon. Early postoperative death was significantly related to: (1) age greater than 70 years; (2) preadmission weight loss greater than 15 pounds; (3) prothrombin time prolonged more than 2.5 seconds; and (4) hepatic metastases. Major complications were encountered in 56% of survivors of percutaneous drainage and 36% of those surviving operation. Intubation of the bile ducts due to inability to bypass the obstruction at operation was associated with the highest mortality (50%) and morbidity (86%). Mean survival was 14 months after operation, compared to 5 months after percutaneous decompression. The authors concluded that percutaneous decompression of the biliary tree is useful palliative treatment for those patients with proximal biliary obstruction due to malignancy when estimated operative risk is high, but operative decompression offers most patients the opportunity for longer survival with lower ultimate mortality and morbidity.
对106例因恶性肿瘤导致胆道系统梗阻且无法切除的患者,评估了手术和经皮方法进行姑息性胆道减压的疗效。70例患者接受了手术减压,36例接受了经皮减压。胰腺和胆管的原发性恶性肿瘤最为常见。72%的患者经皮肝穿刺减压成功,部位在梗阻点以上。接受经皮导管减压的患者总体医院死亡率为25%,接受手术的患者为17%。术后早期死亡与以下因素显著相关:(1)年龄大于70岁;(2)入院前体重减轻超过15磅;(3)凝血酶原时间延长超过2.5秒;(4)肝转移。经皮引流幸存者中有56%、手术幸存者中有36%出现了主要并发症。手术时因无法绕过梗阻而进行胆管插管的患者死亡率最高(50%),发病率最高(86%)。手术后平均生存期为14个月,经皮减压后为5个月。作者得出结论,对于因恶性肿瘤导致近端胆道梗阻且估计手术风险高的患者,经皮胆道减压是一种有用的姑息治疗方法,但手术减压为大多数患者提供了更长生存期、更低最终死亡率和发病率的机会。